All News
RAPID3 in Assessing Psoriatic Arthritis
My research shows that up to 50% of rheumatologists measure something in the course of their daily assessments, and RAPID3 is most popular, being employed by 31% of rheumatologists.
Read Article
Top vasculitis takeaways from ACR 2021
There were several hot topics at ACR21. Here I concentrate on top abstracts in vasculitis.
Read Article
CBD and Opioids in Psoriatic Arthritis: Dr. Eric Ruderman ( @JointMD) reviews abstract #1456 and #1777 presented at the #ACR21 annual meeting.
https://t.co/QnjgjZ13Uq https://t.co/PdbMmcCoIH
Links:
Dr. John Cush RheumNow ( View Tweet)
Frailty in Lupus: Dr. Sheila Reyes ( @RHEUMarampa) reviews abstract #0869 presented at the #ACR21 annual meeting.
https://t.co/5jR74VQBeG https://t.co/AJIhR5Waip
Links:
Dr. John Cush RheumNow ( View Tweet)
Herpes Zoster and Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD) reviews abstract #0981 presented at the #ACR21 annual meeting.
https://t.co/M95XQOBWVf https://t.co/X9vaAEAias
Links:
Dr. John Cush RheumNow ( View Tweet)
JAKi Safety: Dr. Aurelie Najm ( @AurelieRheumo) interviews Dr. Choy about JAKi safety data, including abstracts #0958, #1940 and #1941 presented at the #ACR21 annual meeting.
https://t.co/yZnM9ttDYv https://t.co/eKrocRZdbl
Links:
Dr. John Cush RheumNow ( View Tweet)
Type 1 and Type II Lupus — Patient Perspectives: Dr. Mehta ( @bella_mehta) interviews Dr. Clowse about abstract #1277 presented at the #ACR21 annual meeting
https://t.co/00ojx9rXut https://t.co/bO9chTneoV
Links:
Dr. John Cush RheumNow ( View Tweet)
Redefining Aging
The American College of Rheumatology put together the Community Aging Hub and multiple sessions to help rheumatologists identify gaps in care for older patients with rheumatic diseases
https://t.co/9ciS6oDncK https://t.co/oPZrFU0dmQ
Links:
Dr. John Cush RheumNow ( View Tweet)
GLORIA Study - Is Prednisone Harmful in Elder RA?
The GLORIA study (ABST#1678) was a pragmatic, blinded placebo-controlled randomized trial where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.
https://t.co/eKXjiDpHlc https://t.co/JtCgc1uZnE
Links:
Dr. John Cush RheumNow ( View Tweet)
Osteoporosis in PsA: Dr. Rachel Tate ( @uptoTate) discusses Abstract #1325, presented at the #ACR21 annual meeting.
https://t.co/xnRkPnHeTr https://t.co/nE3ehhCB4j
Links:
Dr. John Cush RheumNow ( View Tweet)
Real Time Monitoring of Disease Activity? There's An App for That: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts #0811 and #0373 presented at the #ACR21 annual meeting.
https://t.co/2qeZjhtMU4 https://t.co/MPCA3oox1U
Links:
Dr. John Cush RheumNow ( View Tweet)
Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan ( @synovialjoints) interviews Dr. FitzGerald about abstract #0490 and other PsA highlights being presented at the #ACR21 annual meeting.
https://t.co/WVgcE8TVpZ https://t.co/1uOafjFWPg
Links:
Dr. John Cush RheumNow ( View Tweet)
RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi ( @MeralElRamahiMD) reports on abstract #0633 presented at the #ACR21 annual meeting.
https://t.co/DO7YXhD3YA https://t.co/vcegdPx8OL
Links:
Dr. John Cush RheumNow ( View Tweet)
First JAKi Failure: What next? Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract #1442 presented at the #ACR21 annual meeting.
https://t.co/NCO8VeNsjb https://t.co/bSN34AFTtt
Links:
Dr. John Cush RheumNow ( View Tweet)
Career Advice for Young Rheumatologists: Drs. Janet Pope ( @Janetbirdope) asks Dr. Bykerk for her career advice for young rheumatologists, during the #ACR21 annual meeting.
https://t.co/jv0eYeFR7M https://t.co/WfYFXPwMtI
Links:
Dr. John Cush RheumNow ( View Tweet)
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 at the #ACR21 meeting.
https://t.co/jWDeA2aZqJ
@drdavidliew @swethaann23 @MeralElRamahiMD @DrMiniDey @doctorRBC https://t.co/KcE67BXcvp
Links:
Dr. John Cush RheumNow ( View Tweet)
TNF Inhibitors Rise to the Top: Drs. Janet Pope ( @Janetbirdope) and David Liew ( @drdavidliew) discuss TNF inhibitor data presented at the #ACR21 annual meeting, including abstracts #0087, #0990 and #0958.
https://t.co/G02P1vG7VQ https://t.co/BLZX5BPzEF
Links:
Dr. John Cush RheumNow ( View Tweet)
Data from ASN Kidney Wk 2021; US Renal Data System of 275,651 dialysis pts - 15% had gout Vs 85% without gout; Gout pts were older, more male, obese, had more hospitalizations (66 vs 57%), mortality, more CVD, PVD and MI https://t.co/m1d0SJEJjw
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of SpA Abstracts Day 2: Dr. Robert Chao ( @doctorRBC) shares the best of SpA Abstracts from Day 2 of #ACR21.
https://t.co/8oZipxMLCm https://t.co/jAifqBRgVc
Links:
Dr. John Cush RheumNow ( View Tweet)
Early Rheumatoid Arthritis: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Vivian Bykerk about her work in early RA and CATCH (Canadian Early Arthritis Cohort) Study Group, during the #ACR21 annual meeting.
https://t.co/DGazNdTFTU https://t.co/K318MIkxvy
Links:
Dr. John Cush RheumNow ( View Tweet)